Seckinger, A., Delgado, J. A., Moser, S., Moreno, L., Neuber, B., Grab, A. L., . . . Vu, M. D. (2017). Target expression, generation, preclinical activity, and pharmacokinetics of the BCMA-T cell bispecific antibody EM801 for multiple myeloma treatment. Cancer cell, 31(3), . https://doi.org/10.1016/j.ccell.2017.02.002
Chicago-Zitierstil (17. Ausg.)Seckinger, Anja, et al. "Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment." Cancer Cell 31, no. 3 (2017). https://doi.org/10.1016/j.ccell.2017.02.002.
MLA-Zitierstil (9. Ausg.)Seckinger, Anja, et al. "Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment." Cancer Cell, vol. 31, no. 3, 2017, https://doi.org/10.1016/j.ccell.2017.02.002.